Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Exelixis Inc (EXEL)

29.44 1.44 (5.14%)

01-22 16:00

Open:

28.56

Pre. Close:

28

High:

29.5499

Low:

28.02

Volume:

3,830,170

Market Cap:

8710M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

29.594 - 29.714

29.714 - 29.837

Low:

27.737 - 27.857

27.857 - 27.98

Close:

29.236 - 29.452

29.452 - 29.675

Technical analysis  (as of: 2018-01-22 4:24:53 PM)

Overall:

      

Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.

Target:

Six months: 37.61     One year: 43.93

Support:

Support1: 28.29    Support2: 25.88

Resistance:

Resistance1: 32.20    Resistance2: 37.61

Pivot:

29.95

Moving Averages:

MA(5): 28.49     MA(20): 29.93

MA(100): 27.07     MA(250): 24.42

MACD:

MACD(12,26): 0.22     Signal(12,26,9): 0.58

%K %D:

%K(14,3): 36.48     %D(3): 30.57

RSI:

RSI(14): 52.67

52-Week:

High: 32.5  Low: 16.72  Change(%): 58.9

Average Vol(K):

3-Month: 283949  10-Days 349935

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
EXEL has closed above bottom band by 40.5%. Bollinger Bands are 21.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 10 Jan 2018 15:33:45 GMT
4 Reasons Exelixis, Inc. More Than Doubled in 2017

Thu, 04 Jan 2018 19:18:45 GMT
The Secret Sauce Behind Exelixis, Inc.'s 12% Move Higher in December

Tue, 16 Jan 2018 21:56:15 GMT
Exelixis and Ipsen Announce Phase 3 Trial Results of Cabozantinib ...

Mon, 22 Jan 2018 12:22:30 GMT
These stock's have rarely let down their investors: PhaseRx, Inc. (PZRX ...

Tue, 09 Jan 2018 09:45:00 GMT
Exelixis: Continued Upside In 2018

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

295.85

Shares Float (M)

291.00

% Held by Insiders

1.60

% Held by Institutions

88.50

Shares Short (K)

16853

Shares Short Prior Month (K)

19880

Stock Financials

EPS

0.510

EPS Est. Current Year

0.280

EPS Est. Next Year

0.670

EPS Est. Next Quarter

0.090

Forward EPS

0.780

Book Value (p.s.)

34.700

PEG Ratio

1.24

Profit Margin

34.82

Operating Margin

41.14

Return on Assets (ttm)

26.0

Return on Equity (ttm)

111.2

Qtrly Rev. Growth

145.2

Gross Profit (p.s.)

1.343

Sales Per Share

EBITDA (p.s.)

0.571

Qtrly Earnings Growth

Operating Cash Flow (M)

193.26

Levered Free Cash Flow (M)

128.66

atoplab.com

Valuation

P/E

57.73

P/E Growth Ratio

0.05

P/BV

0.85

P/S

6177179648.00

P/CF

45.07

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.